https://www.coindesk.com/policy/2023/02/16/canada-close-to-tightening-rules-for-crypto-exchanges-sources/?utm_campaign=coindesk_main&utm_source=twitter&utm_content=editorial&utm_term=organic&utm_medium=social
HC Wainwright & Co. Reiterates Buy on Syros Pharmaceuticals, Maintains $15 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Syros Pharmaceuticals (NASDAQ:SYRS) with a Buy and maintains $15 price target.